BlackRock Inc. - ALLSCRIPTS HEALTHCARE SOLUTN ownership

ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 219 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of ALLSCRIPTS HEALTHCARE SOLUTN
ValueSharesWeighting
Q3 2023$236,397,168
-4.9%
17,990,652
-8.8%
0.01%0.0%
Q2 2023$248,480,543
-6.9%
19,720,678
-3.6%
0.01%
-12.5%
Q1 2023$266,992,392
-27.6%
20,459,187
-2.1%
0.01%
-33.3%
Q4 2022$368,727,897
+16.3%
20,902,942
+0.4%
0.01%
+9.1%
Q3 2022$317,155,000
+1.4%
20,824,290
-1.3%
0.01%
+10.0%
Q2 2022$312,810,000
-39.6%
21,093,091
-8.3%
0.01%
-28.6%
Q1 2022$517,979,000
+17.7%
23,000,787
-3.5%
0.01%
+27.3%
Q4 2021$439,969,000
+50.8%
23,846,502
+9.3%
0.01%
+37.5%
Q3 2021$291,710,000
-35.7%
21,818,383
-11.0%
0.01%
-38.5%
Q2 2021$453,932,000
+23.0%
24,523,533
-0.2%
0.01%
+18.2%
Q1 2021$369,094,000
+3.3%
24,581,704
-0.6%
0.01%0.0%
Q4 2020$357,160,000
+70.4%
24,734,113
-3.9%
0.01%
+37.5%
Q3 2020$209,597,000
+14.6%
25,749,058
-4.7%
0.01%
+14.3%
Q2 2020$182,921,000
+24.5%
27,019,701
+29.5%
0.01%0.0%
Q1 2020$146,934,000
-29.4%
20,871,494
-1.5%
0.01%
-12.5%
Q4 2019$208,078,000
-11.6%
21,200,086
-1.1%
0.01%
-20.0%
Q3 2019$235,277,000
+4.1%
21,427,801
+10.3%
0.01%0.0%
Q2 2019$225,993,000
+17.0%
19,432,061
-4.0%
0.01%
+11.1%
Q1 2019$193,188,000
-1.7%
20,250,462
-0.7%
0.01%
-10.0%
Q4 2018$196,579,000
-31.3%
20,392,048
+1.6%
0.01%
-16.7%
Q3 2018$286,027,000
+18.0%
20,072,189
-0.7%
0.01%
+9.1%
Q2 2018$242,462,000
+0.0%
20,205,195
+2.9%
0.01%
-8.3%
Q1 2018$242,389,000
-13.7%
19,626,646
+1.6%
0.01%
-7.7%
Q4 2017$280,986,000
+5.9%
19,311,850
+3.6%
0.01%0.0%
Q3 2017$265,334,000
+11.5%
18,646,082
+0.0%
0.01%0.0%
Q2 2017$237,922,000
+28.1%
18,645,884
+27.3%
0.01%
+30.0%
Q1 2017$185,724,000
+14999.5%
14,646,995
+12058.5%
0.01%
+400.0%
Q4 2016$1,230,000
-28.7%
120,467
-8.0%
0.00%0.0%
Q3 2016$1,726,000
+14.7%
130,988
+10.6%
0.00%0.0%
Q2 2016$1,505,000
+39.4%
118,487
+45.0%
0.00%0.0%
Q1 2016$1,080,000
-2.5%
81,739
+13.5%
0.00%0.0%
Q4 2015$1,108,000
+23.8%
72,041
-0.3%
0.00%
+100.0%
Q3 2015$895,000
+3.9%
72,281
+14.8%
0.00%0.0%
Q2 2015$861,000
+15.1%
62,948
+0.6%
0.00%0.0%
Q1 2015$748,000
-80.5%
62,593
-79.2%
0.00%
-80.0%
Q4 2014$3,839,000
+5307.0%
300,646
+5626.6%
0.01%
Q3 2014$71,000
-16.5%
5,2500.0%0.00%
Q2 2014$85,000
-52.2%
5,250
-46.6%
0.00%
Q1 2014$178,000
-44.5%
9,840
-52.6%
0.00%
-100.0%
Q4 2013$321,000
+3.9%
20,739
-0.2%
0.00%0.0%
Q3 2013$309,000
+10.0%
20,786
-4.1%
0.00%0.0%
Q2 2013$281,00021,6640.00%
Other shareholders
ALLSCRIPTS HEALTHCARE SOLUTN shareholders Q4 2020
NameSharesValueWeighting ↓
Tamarack Advisers, LP 1,500,000$21,593,0004.50%
KESTREL INVESTMENT MANAGEMENT CORP 445,500$6,433,0003.14%
Adirondack Research & Management Inc. 155,088$2,239,0003.06%
SHAPIRO CAPITAL MANAGEMENT LLC 9,398,617$135,716,029,0002.92%
Waterfront Wealth Inc. 136,976$1,978,0001.40%
Smith, Graham & Co., Investment Advisors, LP 1,008,283$14,560,0001.34%
S&T BANK/PA 475,184$6,862,0001.23%
PARADIGM CAPITAL MANAGEMENT INC/NY 1,132,500$16,354,0000.98%
HENNESSY ADVISORS INC 1,024,100$14,788,0000.95%
BEACONLIGHT CAPITAL, LLC 208,546$3,011,0000.91%
View complete list of ALLSCRIPTS HEALTHCARE SOLUTN shareholders